NCT06432907 StereoEEG Motor Neuronal Potentials Decoding
| NCT ID | NCT06432907 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Research Center of Neurology, Russia |
| Condition | Drug Resistant Epilepsy |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2024-06-06 |
| Primary Completion | 2026-12-25 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2024-06-06 with a primary completion date of 2026-12-25.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goals of this study are (1) to evaluate the rate of stereoEEG brain-computer interface (BCI) classification accuracy and (2) to collect the dataset of neuronal signals recorded from stereoEEG electrodes during motor performance, motor imagery or brain-computer interface control. The study enrolls hospitalised patients suffering from resistant epilepsy with already implanted intracranial stereoEEG electrodes for medical reasons (i.e. for preoperative localization of the epileptogenic foci). The number and location of electrodes are determined solely for the clinical purposes of stereoEEG monitoring and are not related to the protocol of the current study. After obtaining informed consent to participate in the study, each patient will participate in one experimental session lasting no more than 60 minutes, recording brain signals associated with hand movement, motor imagery, and BCI control. All tasks and instructions presented during the study session are not pro-epileptogenic and cannot provoke an epileptic attack. The experiments will take place in the patient's room, without interruption of observation by the department's medical staff. The data recorded in this study will be used to improve or develop new algorithms for decoding motor signals from deep brain structures for their potential use in invasive BCIs.
Eligibility Criteria
Inclusion Criteria: * male and female patients who have had stereoEEG electrodes implanted for medical reasons; * voluntary informed consent to participate in the study; * age from 18 to 70 years. Exclusion Criteria: * patient refusal to participate in the study; * cognitive impairment that prevents following the study instructions; * severe visual impairment that does not allow viewing visual instructions on a computer screen; * upper limb paresis or other motor disorders; * pain in the hand of any etiology; * any acute diseases, exacerbation of chronic diseases, acute life-threatening conditions; * occurrence of an epileptic attack during the experiment.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06432907 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Drug Resistant Epilepsy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06432907 currently recruiting?
Yes, NCT06432907 is actively recruiting participants. Contact the research team at lesya.md@yandex.ru for enrollment information.
Where is the NCT06432907 trial being conducted?
This trial is being conducted at Moscow, Russia.
Who is sponsoring the NCT06432907 clinical trial?
NCT06432907 is sponsored by Research Center of Neurology, Russia. The trial plans to enroll 30 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.